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Abstract 
Magnesium and magnesium alloys are emerging as possible novel biodegradable materials for 
medical implants such as cardiovascular stents. Understanding the angiogenic properties of 
magnesium would increase the level of knowledge regarding the healing process once the 
material is implanted.  The chick chorioallantoic membrane assay is an effective, inexpensive 
method of assessing magnesium’s angiogenic properties.  The assay is more informative than an 
in vitro model, in terms of magnesium degradation environment, and provides similar results of 
an in vivo model.  This model can be used as a preliminary method of assessing results before 
investing labor and finances into larger in vivo models.  The corrosion results of magnesium 
alloys in an in vivo environment and in vitro environment yield insight towards the byproducts 
of the implant, once degradation has occurred. Immersion test results compared to the in vivo 
chorioallantoic membrane assay results have shown the behavior of two specific magnesium 
alloys-AZ31 and Mg-5Zn-0.3Ca.  Full comprehension of the angiogenic process stimulated by 
magnesium will assist in the development of magnesium implants that are more effective 
treatment methods for many medical applications.
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CHAPTER 1 
Introduction 
1.1 Introduction 
 At the helm of developing implants, biodegradable materials are at the forefront of new 
science initiatives.  Aimed at reducing subsequent surgeries and providing beneficial elements to 
the body, biodegradable implants comprised of magnesium are the front runners as a new 
implantable material that is beneficial in the treatment of a various medical conditions, as well as 
providing an important element to the body.  The focus of the research conducted was to 
evaluate the effects of magnesium, magnesium alloys, and degradation products on angiogenesis, 
utilizing the chicken chorioallantoic membrane assay.  The aim was to show that magnesium, 
magnesium alloys, and degradation byproducts are capable of upregulating angiogenesis in the 
tissues that are in direct contact with the research sample.  
1.2 Objective 
The focus of the research plan proposed by the Engineering Research Center for 
Revolutionizing Metallic Biomaterials is to fabricate and commercialize magnesium based 
biodegradable biomaterials that will regenerate biological functions in craniofacial, orthopedic, 
cardiovascular, and responsive biosensor applications.  The objective of this study was to utilize 
the chick chorioallantoic membrane assay as a viable method to analyze the effects of 
magnesium and magnesium based alloys on angiogenesis.  Post implantation angiogenesis is 
critical to healing at the site, the research performed in this study will provide ground level 
knowledge of the interactions that occur between developing vasculature and Engineering 
Research Center fabricated magnesium based alloys.  
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CHAPTER 2 
Literature Review 
2.1 Biodegradable Metals 
 Biomaterials for implants can be comprised of a variety of materials.  Material selection 
is dependent upon site, use, and duration the implant is required.  Biomaterials that have been 
used to fabricate implants include, but not limited to, ceramics, composites, metals, and 
polymers.  Metals have a high wear resistance, increased strength, increased toughness, and high 
ductility, in comparison to other biomaterials.  Traditionally, scientist and surgeons opted for 
metals that were corrosion resistant, such as titanium and stainless steel.  Interest has increased in 
the scope of supplying implants that are beneficial to the healing and health of the patient.  The 
combination of health consciousness with modern developments has paved the way for 
biodegradable implants.  Materials that can be fabricated to provide strength and integrity, in 
addition to beneficial corrosion by products, have shifted the focus of biomaterial development.   
The material for biodegradable stents is requested to have at least the following 
characteristics:  it must be biocompatible, degradation products of the material must also be 
biocompatible, the material must stay in the placed for several months before its complete 
bioabsorption and the radial force of the resultant stent must be enough for scaffolding effect 
during the request period (Moravej & Mantovani, 2011).  The purpose of biodegradable implants 
and coatings is to support tissue regeneration and healing in a specific application by material 
degradation and concurrent implant replacement through the surrounding tissue (Witte et al., 
2008).  Degradable metallic materials could potentially replace corrosion-resistant metals 
currently used for stent application as it has been shown that the role of stenting is temporary and 
limited to a period of 6-12 months after implantation during which arterial remodeling and 
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healing occur (Mantovani, 2011; Moravej & Mantovani, 2011).  The candidate materials for 
biodegradable stent application should have properties in comparison to stainless steel 316L, 
which is the current gold standard.     
Table 1 
Mechanical and physical properties of implant materials in comparison to natural bone 
Properties Natural Bone Magnesium Titanium Stainless Steel 
Density (
 
   
) 1.8-2.1 1.74-2.0 4.4-4.5 7.9-8.1 
Elastic modulus (GPa) 3-20 41-45 110-117 189-205 
Compressive yield strength (MPa) 130-180 65-100 758-1117 170-310 
Fracture toughness (MPam
1/2
)
 
3-6 15-40 55-115 50-200 
 
Development of biodegradable metallic implants has revolutionized the concept of 
biomaterials from purely mechanical replacement devices towards true biological solutions 
(Moravej & Mantovani, 2011).   Although corrosion is generally considered as a material failure, 
when the resultant corrosive byproducts are advantageous to the patient, corrosion of the material 
becomes acceptable (Moravej & Mantovani, 2011).  The ability of magnesium to corrode into 
beneficial by products is advantageous to scientist, surgeons, and most importantly, patients.  
The purpose of these biodegradable implants is to promote tissue regeneration and optimal 
healing, facilitated by the degradation by products.  It is desirable for these implants have 
minimal impact on the surround healthy tissue and not elicit a toxic response of the immune 
system.  
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2.2 Magnesium 
Magnesium has become a candidate for biodegradable stent application based on the fact 
that it is found in several tissues and biochemical reactions in the body.  Magnesium is the 
second most abundant intracellular cation and fourth most abundant mineral in the body.  Fifty 
percent of the magnesium that is found in the body is located in bone, with the rest being 
dispersed amongst tissues and cells of the body.  One percent of magnesium is found in the 
blood, yet this is very critical to regulating magnesium levels throughout the body.  The essential 
element is a substantial intercellular cation which is involved in more than 300 biological 
reactions of the cell(Moravej & Mantovani, 2011).  The magnesium intake for a normal adult 
should be 300-400 milligrams per day, with excess magnesium efficiently being excreted to the 
body without causing deleterious effects (Song, 2007).  Magnesium maintains normal muscle 
and nerve function, helps to maintain a healthy heart rhythm, aids in maintaining the immune 
system, and it keeps bones strong.  Magnesium is also known to play a role in energy 
metabolism, or the regulation of ATP and protein synthesis.   
In 1808, elemental magnesium was discovered by Sir Humphrey Davy.  Dr. Edward C. 
Huse began using magnesium wires in 1878 to fabricate ligatures for his patients.  Based on his 
observation of the degradation of the wires, dependent upon the size of the wire, the application 
of metallic biodegradable implants began shortly thereafter(Moravej & Mantovani, 2011). 
Magnesium is a desirable material for biodegradable metals used for implants due to its high 
biocompatibility.  The mechanical properties of magnesium are similar to the mechanical 
properties of cortical bone.  Maier et al researched the effects of magnesium on endothelial cell 
migration and proliferation to discover that high levels of magnesium facilitates the 
reendothelialization of vascular injuries, thus preventing excessive subintimal proliferation of 
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smooth muscle cells and reducing the risk of thrombosis, when human umbilical vein endothelial 
cells were exposed to magnesium (Maier, Bernardini, Rayssiguier, & Mazur, 2004).  
Reendothelialization is a requirement for healing of tissues following vascular injury which may 
result from surgery or any other impact to the vascular system. 
Magnesium is highly corrosive in environments with high chloride content.  The 
degradation of magnesium and magnesium alloys occurs via corrosion.  Corrosion is a chemical 
or electrochemical reaction that occurs between a metal and its environment.  Corrosion is 
triggered by varying temperatures, metal heat treatment during fabrication, metal surface 
conditions, exposure to radiation, exposure to environmental contaminants, pressure and stress to 
the metal, and other miscellaneous factors.  Corrosion may be uniform, galvanic, crevice, or 
occur via pitting.  The corrosion of a metal may be induced by stress cracking the surface, 
erosion of the metal, or damage caused by the presence of hydrogen.  The surface ions of the 
metal become oxidized, or they lose electrons, while the exposed agent gains those electrons, 
thus being reduced.   
Galvanic corrosion is the most commonly known form of corrosion and is a result of 
differing oxidation potentials for metallic ions.  The larger this difference, the increased amount 
of galvanic corrosion that occurs.  The degradation of magnesium occurs primarily by galvanic 
corrosion.  The degradation of magnesium alloys always leads to hydrogen evolution and 
alkalization of the solution (Song, 2007).  The pH of a solution must be greater than 11 for 
magnesium to form a protective layer to halt corrosion.  This very basic pH level is not ideally 
found in normal body conditions.  Hastened degradation of magnesium due to the chemical 
composition of the body has a significant impact on the mechanical properties of magnesium 
(Mantovani, 2011).  In the human body, the evolved hydrogen bubbles from a corroding 
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magnesium implant can be accumulated in gas pockets next to the implant, which severely 
impacts healing times of the site.  Tissue necrosis can has been shown to increase due to 
hydrogen gas formation. 
Around 1900, Payr already proposed that tissue oxygen and water content, carbon 
dioxide, the dissolved salts in blood and the chemical processes in cells were mainly responsible 
for the corrosion of magnesium in vivo (Witte, 2010). In an effort to control the rate of 
degradation of magnesium, the material is can be coated with a biocompatible material.  
Biodegradable layers of PLGA and PLLA mixed with a drug is a potential coating for 
magnesium implants.  The PLGA and PLLA allow for slow release of the drug, while allowing 
the magnesium to remain in place for mechanical and structural support.  Lu et al. reported the 
fabrication of biodegradable AZ81 magnesium alloy stent coated with a composite multi-layer 
film for control of the biodegradation rate and drug release rate of the magnesium alloy (Moravej 
& Mantovani, 2011).  The in vitro experimentation concluded that the layer of poly-l-lactic acid 
composite increased the corrosion resistance and controlled the biodegradation rate of the 
material.  Magnesium can also be alloyed with aluminum, manganese, and rare earth elements to 
decrease the rate of corrosion for the material (Mantovani, 2011). Due to magnesium’s capability 
to quickly degrade in chlorinated environments, magnesium is often alloyed with zinc, 
aluminum, and calcium to halt degradation.  Magnesium and its alloys are generally known to 
degrade in aqueous environments via an electrochemical reaction which produces magnesium 
hydroxide and gas (Witte et al., 2008). Song reported that there are two main groups of 
magnesium alloys, those containing aluminum and those that do not.  The biocompatibility of 
magnesium alloys that contain aluminum is poor.  Calcium is often alloyed with magnesium to 
improve strength, decrease the corrosion rate, and improve the biocompatibility of the material.   
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Research has shown that magnesium based biodegradable stents are more biocompatible 
than current permanent stents, but due to the fact that the corrosion rate of the material has 
successfully been controlled, the ideal alloy is yet to be developed (Mantovani, 2011).  In fact, 
the objectives targeted in the development of the next generation of biodegradable metallic stents 
are controllable degradation rate, prolonged mechanical stability and further reduction of impact 
on developing tissues (Mantovani, 2011). 
2.3 Angiogenesis 
Angiogenesis is the physiological process involving the growth of new blood vessels 
from pre-existing vessels.  It is a normal and vital process in growth and development, wound 
healing, and tissue repair.  Angiogenesis is also pathogenic, in that it is responsible for tumor 
malignancy.  The physiological process of angiogenesis is maintained by the balance of growth 
and inhibitory factors.  Abnormal vessel growth is seen in cancer, skin disease, macular 
degeneration, diabetic ulcers, cardiovascular disease, and stroke.   
 
Figure 1. Blood vessel anatomy. From 
http://bme.ccny.cuny.edu/faculty/jtarbell/SMC%20images.htm 
Blood vessels are comprised of three layers-tunica intima, tunica media, and tunica 
adventitia, as outline in Figure 1.  The tunica intima is the innermost layer formed by endothelial 
10 
 
cells that are held together by polysaccharides and connective tissues.  The tunica media is the 
vascular smooth muscle layer of the blood vessel that contains large quantities of connective 
tissue and polysaccharides.  The tone of the blood vessel is regulated by the tunica media.  The 
tunica adventitia is the connective tissue layer that is responsible for the nerve supply to the 
vessel walls.  Angiogenesis occurs from the tunica intima layer.  The endothelium is the thin 
layer of cells that line the interior surface, or lumen, of blood vessels and lymphatic vessels, 
which forms the interface between the circulating blood and lymph.  The cells that form the 
endothelium are endothelial cells and line the entire circulatory system.  Endothelial cells are 
responsible for fluid filtration, blood vessel tone-the resistance to passive stretch during resting 
state, neutrophil recruitment, and hormone trafficking.  Damage to the endothelium by injury, 
whether deliberate, such as in surgery, or unintentional, requires repair.  Healing has to occur 
after any type of injury or surgery.  
 
Figure 2.   The angiogenic process.  (Kalluri, 2003).  
The process of cutaneous wound healing is a complex and carefully orchestrated cascade of 
overlapping events that involves changes in extracellular matrix protein composition, cell 
migration, and proliferation in response to numerous cytokines, Figure 2 (Grzesiak & 
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Pierschbacher, 1995). Crucial to the repair process is the migration of inflammatory cell types 
such as macrophages and neutrophils, epithelial cells, fibroblasts, and endothelial cells into the 
wound site over the course of the first three days after injury, where they have multiple 
responsibilities resulting, ultimately, in a healed wound (Grzesiak & Pierschbacher, 1995).  This 
sequential process of restoring form and often function to the injured tissues is vital.  The 
cascade of events begins with hemostasis, followed by inflammation, cell proliferation, and 
tissue maturation.  Hemostasis is the process of stopping blood flow by clot formation.  When 
tissues are exposed to an initial injurious stimulus, a blood clot is formed from circulating fibrin.  
Circulating chemokines and cytokines are released to recruit cells that phagocytize the damaged 
tissue.   
Following injury, blood flow to the area must be stopped.  Hemostasis occurs in three 
notable phases: vascular phase, platelet phase, and coagulation phase.  The vascular phase occurs 
up to 30 minutes after injury and involves vasoconstriction of the smooth muscle cells of the 
endothelium to slow blood flow.  During the platelet phase, the damaged endothelial cells release 
the blood clotting factor, von Willebrand’s Factor.  Von Willebrand’s Factor allows the 
circulating cells to attach to the surface of the endothelial cells, causing aggregation.  
Aggregation of platelets forms a plug for the blood vessel.  Aggregated platelets function to 
stimulate the release of platelet thromboplastin and thromboxane, which further activates the 
clotting process.  The surfaces of these platelets now serve as a vasoconstrictor.  During the 
coagulation phase of the hemostasis process, fibrinogen is converted into insoluble fibrin which 
attracts circulating aggregated platelets in addition to red and white blood cells to form a more 
stable clot.  Dependent upon the duration of injurious stimulus, it is determined if the tissues are 
in a state of chronic or acute inflammation and which cellular components are recruited to the 
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area.  The intrinsic and extrinsic pathways of coagulation allow fibrinogen to be converted to 
fibrin and coalesce with circulating platelets to form a clot.  The extrinsic pathway is activated 
by extraneous materials to the blood and damaged endothelial wall.  Coagulation Factors III-
Tissue Thromboplastin activates Factor VII, which is calcium dependent, which proceeds to 
activate Factor X-Prothrombin Activator.   The extrinsic pathway is initiated within 12 to 15 
seconds, but due to the rapid duration, the effect is fast acting and not effective in maintaining a 
stable clot.  The intrinsic pathway is stimulated by blood receiving signals from the damaged 
vessel wall.  Clotting Factor XII is activated by the blood cells contacting the damaged 
endothelium, and in turn activates Factor XI.  These two clotting factors activated Factor IX, 
which proceeds to activated Factor VII.  Factor VIII, Factor III, and the required calcium ions 
activate Factor X-Prothrombin Activator.  Despite the fact that both pathways lead to activation 
of Factor X-Prothrombin Activator, the intrinsic pathway is capable of eliciting a long standing 
result.  The clot functions to maintain tissue structural support until the original form can be 
restored.  The platelets are responsible for releasing cytokines and chemokines that 
biochemically attract pro-inflammatory factors, such as prostaglandins, thromboxane, and 
histamine, which cause vasoconstriction or vasodilation of the intact vasculature.   
During the inflammatory phase, damaged tissues are removed by immune cells-
neutrophils, basophils, eosinophils, and macrophages.  Growth factors are also released in the 
area, to allow for cell proliferation and migration.  This permeability of the blood vessels allows 
the recruitment of the aforementioned immune cells.   
The inflammatory phase of wound healing is then followed by proliferation of cellular 
components to restore the damaged area.  The hallmark characteristics of this phase are 
angiogenesis, collagen deposition, tissue formation, and wound contraction.  Angiogenesis is 
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required to allow the tissues to become oxygenated and continue with growth and development.  
The neovascularization of the tissue assists in the restoration of not only form, but function to the 
area.  This is not to say that is process is always perfect, because aberrations do occur during 
maturation and post-translational modification of the tissues. 
At the cellular level, angiogenesis is initiated by degradation of the basement membrane 
of the parent vessel by the responding endothelial cells (Guedez et al., 2003).  Endothelial cells 
then migrate toward an angiogenic stimulus and proliferate (Auerbach, Lewis, Shinners, Kubai, 
& Akhtar, 2003).  Angiogenesis occurs in four steps:  stimulation of endothelial cells by 
angiogenic factors, degradation of the capillary basal lamina by activated endothelial cells via 
extracellular proteinases, capillary formation and migration of endothelial cells, and new vessel 
maturation. Angiogenic growth factors activate receptors present on endothelial cells.  
Angiogenic growth factors stimulate blood vessel growth.  Under normal physiological 
condition, angiogenic growth factors are produced in balance with angiogenesis inhibitors.  
Physiological imbalance of angiogenic growth factors and inhibitors encourage aberrations. 
Table 2 
List of growth factors and the function they have on angiogenesis 
Growth Factor Function 
Fibroblast Growth Factor Promotes proliferation and differentiation of endothelial cells, 
smooth muscle cells, and fibroblasts 
Vascular Endothelial 
Growth Factor 
Affects permeability 
Angiopoietins (Ang1 and 
Ang2) 
Stabilize vessels 
Platelet Derived Growth 
Factor 
Recruit smooth muscle 
Integrins Bind matrix macromolecules and proteinases 
Basic fibroblast growth 
Factor 
Induces endothelial cell migration, proliferation, and tube 
formation 
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Basic fibroblast growth factor (bFGF) is the angiogeneic growth factor that is active 
during the stimulation of endothelial cells by other angiogenic factors. bFGF is a potent inducer 
of endothelial cell migration, proliferation, and tube formation.  bFGF is a tyrosine kinase 
receptor.  Vascular endothelial growth factor (VEGF) is specific for endothelial cells.  VEGF is 
responsible for inducing extracellular proteinase expression, expression of specific integrins for 
migration.  VEGF is capable of initiating cell proliferation and migration by binding specific 
endothelial cell receptors-Flt-1 and Flk-1.  Flt-1 is a protein kinase receptor responsible for cell 
proliferation and differentiation.  Flk-1 is also a tyrosine kinase receptor that is expressed on 
endothelial cells, but is responsible for other processes such as neurogenesis and vasculogenesis.  
The inactivation of p53 and experiencing levels of decreased oxygen inactivate VEGF.  Research 
has shown that using drugs to coat biodegradable stents results in injured arterial walls and 
severely impacts surrounding tissue, delaying reendothelialization of the area.  Vascular 
endothelial growth factor is a potent endothelium-specific angiogenic factor, which may assist in 
promoting reendothelialization of the denuded arterial wall (Wang et al., 2010).  
The activated endothelial cells release proteases that degrade the basement membrane to 
allow endothelial cells to escape.  These newly freed endothelial cells are then allowed to 
proliferate, or increase in number, into the surrounding matrix, connecting with neighboring 
vessels.  Degradation of the capillary basal lamina by activated endothelial cells via extracellular 
proteinases matrix metalloproteinases and urokinase.  Matrix metalloproteinases (MMPs) are 22 
zinc dependent endopeptidases that degrade extracellular matrix components.  The specific 
metalloproteinases activated during angiogenesis are: MMP1, MMP2, and MT1-MMP.  MMP1 
is a collagenase that breaks peptide bonds found in collagen.  MMP2 is a gelatinase, which is a 
proteolytic enzyme that hydrolyzes gelatin into polypeptides, peptides, and amino acids.  MT1-
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MMP is responsible for the actual basal lamina degradation.  Urokinase is responsible for 
converting plasminogen to plasmin.  Plasminogen is an 88 kilo Dalton single stranded plasmin 
precursor synthesized in the liver, stored in eosinophils, and forms complexes with fibrinogen 
and fibrin.  During coagulation, large amounts of plasminogen are integrated in the clot that is 
formed by fibrin, to prevent premature lysis of the clot.  Plasmin is present in the blood and 
functions to degrade blood plasma proteins, namely fibrin.  Plasmin is responsible for activating 
collagenases.  The cleavage of fibrin, fibronectin, thrombospondin, laminin, and von Willebrand 
factor occurs because of plasmin.  The binding of urokinase to the urokinase receptor induces 
cell proliferation and regulation of cell migration. 
Integrins are transmembrane receptors on the surface of many cells that mediate the 
cellular interactions of the angiogenic cascade. Integrins require magnesium and calcium ions to 
function (Grzesiak & Pierschbacher, 1995).  Extracellular magnesium has been well established 
as a receptor-mediated chemoattractant for endothelial cells.  Neovascularization occurs when 
the endothelial cells of a microvessel receive an angiogenic stimulus, resulting in the 
development of sprouts from the parent vessel in the general direction of the signal (Guedez et 
al., 2003).  Integrins are receptors that mediate the attachment between a cell and the tissues that 
surround it, communicating with the extracellular matrix of the surrounding tissues.  The 
information that is communicated by the integrins to the extracellular matrix allows rapid 
biochemical responses to the tissue environment. Sprouts, as the newly formed vasculature is 
termed, grow in length and diameter, forming from the lumen outward.  It is the length and 
diameter of the vessel that differentiate angiogenesis from vasculogenesis.  Vasculogenesis is the 
formation of new blood vessels from stem cells, it mainly occurs during embryogenesis.  The 
location and size of the blood vessel corresponds to the influence of the growth factors, the 
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specificity of post-translational modification by neighboring organs, and occasionally pathogenic 
factors, such as tumor formation. Integrin expression present on newly forming vessels allow the 
migration of endothelium cells into the surrounding matrix.  Extracellular proteinases, matrix 
metalloproteinases and urokinase, facilitate the migration of endothelial cells into the 
surrounding matrix.  In order for the new vessel formed from the sprout to mature, angiopoeitin, 
a growth factor whose tyrosine kinase receptors mediate cell signaling to induce tyrosine 
phosphorylation, leads to the binding and activation of other enzymes.  Platelet derived growth 
factor, which is produced by the endothelial cells of the newly formed vessels, are responsible 
for the recruitment of smooth muscle cells.  
Bioengineers have been charged with the task of developing ideal biodegradable 
magnesium based implants.  A promising strategy to increase the success of tissue healing, 
regeneration, and integration of the developing implant lies in the key process of 
revascularization which is crucial in improving the successful integration of implants both in 
vitro and in vivo (Poh, Shi, Lim, Neoh, & Wang, 2010).  Understanding the angiogenic 
properties of magnesium would increase the level of knowledge regarding the healing process 
once the material is implanted.  It is important to have a vast comprehension of the impact of 
magnesium on further growth and development of the tissue.  Improving the revascularization of 
the area often requires delivery of angiogenic growth factors to localized tissues to stimulate 
angiogenesis.  Vascular endothelial growth factor is the most potent and widely used key 
regulator of angiogenesis (Wang et al., 2010).  Vascular endothelial growth factor is not only 
critical to angiogenesis, but is also known to function during bone repair by promoting the 
cellular functions of osteoblasts-proliferation, migration, and differentiation-and indirectly 
affecting the function of osteoclasts in the cellular environment (Poh et al., 2010).  
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Immobilization of angiogenic growth factors onto the surface of metal substrates may be a viable 
approach in promoting revascularization and enhanced implant integration in a controllable 
manner (Poh et al., 2010). 
A number of in vivo systems have been developed to understand angiogenesis, including 
the rabbit cornea model, the chick chorioallantoic membrane (CAM) assay, and vitelline 
membrane (VIM) assays (Scott, 2004).  These systems are impractical for the study or screening 
of large number of samples and are far removed from angiogenesis observed in a human system 
(Scott, 2004). 
2.4 Research Models  
2.4.1 In vitro research models. In vitro research methods involve simulating a 
biological environment.  In vitro research methods serve as a foreshadowing to what is to be 
expected when an experiment is conducted in a biological environment.  Simulating biological 
conditions prior to conducting in vivo experiments provide insight on expected results.  The 
chemical composition of the environment where the implant will be placed is important in 
pondering the effects of the degradation byproducts.  Exploring what those products are in an in 
vitro environment allows better understanding of how the material will perform in an in vivo 
experiment.  If the desired results are not garnered, this research methods aids in developing new 
alloys that have the ideal degradation properties.  Immersion test of magnesium alloys AZ31 and 
Mg-5Zn-0.3Ca were conducted in Hank’s simulated body fluid.  Hank’s simulated body fluid is 
a highly saline solution that has been used repeatedly to assess a materials ability to bind with 
bone.  When held to physiological temperature of 37°C, this solution causes the formation of 
hydroxyapatite on the surface of the material.  The assessment of the presence and extent of 
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hydroxyapatite formation on the surface of the metal enables conclusions to be drawn on the 
effectiveness of the research sample. 
2.4.2 In vivo research models.  In vivo research models encompass a broad variety of 
specimens.  From zebra fish to human subjects, in vivo experiments can provide a large amount 
of information.  When financial and available resource limitations impact a desired research 
plan, smaller animal models are available.  Many researchers desire to evaluate their research on 
smaller, inexpensive methods prior to investing large amounts of time and financial resources 
into costly large animal or human models.  Currently the department of Bioengineering does not 
have the financial or laboratory resources available to conduct large animal model research.  The 
chicken chorioallantoic membrane assay is an ideal in vivo research model to utilize under these 
conditions.  The Institutional Animal Care and Use Committee does not recognize developing 
embryos as an animal model, since the embryo is not technically an animal at this point.  The 
information provided by smaller animal models often provide enough preliminary data to 
determine if it is ideal to pursue larger animal models.  
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Table 3 
Comparison of the Chicken Chorioallantoic Membrane Assay to large Mammalian Models 
(Valdes et al., 2002) 
2.5 Chorioallantoic Membrane and the Chick Chorioallantoic Membrane Assay 
  The original chorioallantoic membrane assay was developed by experimental 
embryologists more than 50 years ago and has long been a mainstay for the study of embryonic 
organ development (Auerbach et al., 2003).  The underlying principle of the chorioallantoic 
membrane assay is the measurement of time dependent occurrence of effects on the 
Chick Embryo CAM Model Mammalian Models 
Low cost (eggs, time, labor, etc.) Moderate to high cost (rats-dogs, per diem, 
time, labor, etc.) 
Complete in vivo environment Complete in vivo environment 
Very simple surgery to place implants More complex surgery to place implants (i.e., 
requires anesthesia, operating room) 
Allows direct, continuous visualization of 
implant site through window 
Does not allow visualization of implant site 
Animals do not need to be restrained Animals often have to be restrained 
Maximum implantation time of about 2 weeks Implantation time can be several years 
Allows evaluation of both acute and chronic 
inflammation (up to 2 weeks) 
Allows evaluation of both acute and chronic 
inflammation 
Allows evaluation of granulation tissue in 
response to injury, including neovascularization. 
Allows evaluation of granulation tissue in 
response to injury, including 
neovascularization. 
Fibrosis seen in response to tissue injury and 
implants. 
Fibrosis seen in response to tissue injury and 
implants. 
Tissue and blood sampling is easily done (i.e., 
through window) but amount is limited 
Tissue and blood samples are available in 
larger quantity but require more invasive 
procedures 
Biology/physiology of this model is well known 
(e.g., been used for toxicity, tumor, 
angiogenesis studies) 
Biology/physiology of this model is well 
known 
Cost-effective model for utilization of expensive 
and limited reagents (e.g., cytokines, antibodies) 
Cost-ineffective model for utilization of 
expensive and limited reagents (e.g., 
cytokines, antibodies) 
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chorioallantoic membrane when exposed to a test item (Scheel et al., 2011).  Requiring twenty 
one days to develop from fertilized embryo to chick, makes the chick chorioallantoic membrane 
assay a quick, inexpensive, efficient research model that provides information similar to small 
animal research models.   In researching ideal models for in vivo studies, it is important that the 
model mimic what may occur in large animal models and human clinical trials.  The use of a 
developing embryo allows for understanding of the reaction that a biomaterial will have with this 
environment.  The chicken chorioallantoic membrane provides an environment that is vast with 
proteins, growth factors, and a dynamic environment. The fact that the developing embryo lacks 
a mature immune system means the tissue responses will be similar to an acute and chronic 
inflammatory response that would be elicited in mammalian models.  Current models that are 
used for assessing tissue response to biomaterials are expensive, laborious, and may not offer 
direct visualization of the changes that are being modulated by the presence of the material being 
tested.  The chorioallantoic membrane assay was discovered in the 1970’s as an alternative to the 
controversial Draize’s eye assay that was conducted from rabbit specimens.  The chorioallantoic 
membrane assay is an inexpensive method of assessing biological processes such as transport, 
gas exchange, tumor transplant, toxicity and angiogenesis.  The advantages of using a 
mammalian model are the same with the chorioallantoic membrane assay.  The chorioallantoic 
membrane assay is beneficial in being able to achieving similar results in a shortened time 
period. 
Upon fertilization of the egg by the rooster, the yolk enters the oviduct of the hen.  
Albumen is added to the yolk and the yolk and albumen are covered by the shell.  The egg is 
released from the oviduct into the external environment.  The temperature change from inside the 
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hen to the external environment, causes the contents of the egg shell to retract away from the 
shell, and form an air sac, which provides space for the embryo to develop.   
 
Figure 3. Illustration of the developing chick embryo depicting the representative membranes 
and egg contents. (Carothers, 2011). 
The contents of the fertilized chicken egg are depicted in Figure 3.  The chicken embryo is 
comprised of several embryonic membranes that are vital in the growth and maturation of the 
embryo into a chicken.  The yolk sac is responsible for providing the embryo with nutrients and 
food, the amnion encloses the embryo and provides protection, the allantois is the respiratory 
organ for the embryo.  The allantoic vessels are responsible for carrying sodium and calcium to 
the embryo and waste away from the embryo into the allantoic membrane.  This membrane is 
pivotal in the developing embryo’s vascularization.  From the point of fertilization, the 
chorioallantoic membrane is forming via vasculogenesis within the embryo and is fully 
developed during days eight through ten.  The embryo becomes fully encased by the 
chorioallantoic membrane by day twelve.  Days four through eight are when most angiogenic 
activity is occurring within the developing embryo.  This is the most ideal time periods to assess 
the interaction between a biomaterial and angiogenesis. 
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Angiogenesis is indicative of protein adsorption and its dependence on the chemical 
structure of the biomaterial.  Even though the avian model may elicit a different cell type than a 
mammalian model, the cells essentially have the same function.  The inflammatory process for 
the avian model is similar to that of the mammalian model.  Both models release chemotactic 
triggers to recruit inflammatory cells to the region.  Since this model can be used to measure 
incorporation of the biomaterial, this model is also useful in assessing surface modifications of 
the biomaterial that would promote cell adhesion and tissue growth. 
 
Figure 4. Angiogenic changes of the CAM after exposure to gelatin sponges that are urokinase 
plasminogen activator-transfected endothelial cells (uPA-R5) seeded (A), parental endothelial 
cells seeded (B), and the gelatin sponge without cells (C). ( Ribatti, 2010).   
Figure 4 shows the surface modifications of the chorioallantoic membrane that has been 
infiltrated with gelatin sponges.  The gelatin sponges contain urokinase plasminogen activator-
transfected endothelial cells and parental endothelial cells.  An unseeded gelatin sponge was used 
as the control.  Angiogenic changes towards the asterisk are displayed in Figure 4A and 4B, in 
response to the cell seeded gelatin sponge.  There were no notable angiogenic changes observed 
in Figure 4C.  Sequential photographic images were analyzed to formulate these conclusions. 
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The chorioallantoic membrane assay is relatively inexpensive, in that few laboratory 
supplies are required to prepare the egg for implantation.  Fertilized eggs are sterilized and 
allowed to incubate for three days prior to placing any material on the allantoic membrane.  
Albumen is extracted from the fertilized egg to increase the air space and provide room for the 
desired materials to become implanted.  Two to three microliters of albumen are extracted via 
syringe.  This opening is then sealed.  Research specimens are placed on the surface of the 
chorioallantoic membrane for investigation. 
Previous studies have shown that the chorioallantoic membrane assay is capable of 
eliciting a mild acute inflammatory response and angiogenic response.  These responses are 
required for increased healing after implantation of a biomaterial into the body.  Rough surfaces 
of the material aid in incorporation into the chorioallantoic membrane.  Although polishing 
makes the surface of the sample relatively smooth, the surface of the oxide layer is often present 
in most samples used during experimentation.  
The limitation of the chorioallantoic membrane assay in understanding the effects of an 
alloy and its degradation properties on angiogenesis is that development of the membrane and 
angiogenic activity is highest during days 3 through 12.  When a sample requires extensive 
amounts of time to degrade, those longer than 9 days, assessment does not provide a complete 
picture of the full extent of the correlation.  Materials that are not quickly dissolved may not be 
ideal for this research model.  Distinguishing between angiogenesis that occurs innately from 
angiogenesis in response to a test material, without the use of histological testing, is also a 
limitation of the chorioallantoic membrane assay (Ribatti et al., 2001). Table 2 lists a few 
advantages and disadvantages of the chick chorioallantoic membrane assay. 
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Table 4 
Advantages and disadvantages of the chorioallantoic membrane assay 
Advantages Disadvantages 
Easy methodology Difficult monitoring 
Sterility is not required Non-specific inflammatory reactions 
Reproducibility Preexisting vessels 
Reliability Sterility is not required 
(Ribatti, 2010). 
The methodology of utilizing the chick chorioallantoic membrane assay is relatively easy, with 
difficulties arising from egg opening methods.  The lack of a required sterile environment can be 
considered as advantageous and disadvantageous.  It is an advantage because the eggs can be 
opened in any location, not requiring the use of specialized laboratory equipment, if it is not 
available.  Lack of sterility can be considered a disadvantage for experimental methods that 
provided the ideal environment and nutrient source for bacteria and mold, which is provided by 
the incubator and the developing embryo.  Dependent upon the development period at which the 
implant is placed on the chorioallantoic membrane surface, the presence of preexisting vessels 
may affect analysis of vasculature that has developed as a result of the test material. It is vital to 
consistently document angiogenic changes.  Consistent methods of quantifying angiogenesis are 
also a limitation of use of this model.    
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Figure 5.  Methods of quantifying angiogenesis based on angiogenesis that occurs within a 
defined area (a), the intensity of angiogenic changes that occur (b), and skeletonized image 
reconstruction of the chorioallantoic membrane for software analysis (c). (Ribatti, 2010).   
Figure 5 depicts three methods for quantifying angiogenic changes that occur.  When angiogenic 
changes are observed within a defined area, they can be scored based on the branch points that 
occur within or outside of the defined area.  Many researchers have used a scoring system 1-5 
that denotes the angiogenic changes that occur, based on the intensity or the number of newly 
formed blood vessels that are present.  The use of specialized computer software to quantify 
angiogenesis is also an option.    
a 
b 
c 
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2.5.1 Embryo incubation. Embryos used for this study were received from Mountaire 
Farms of Siler City, NC, the North Carolina Agricultural and Technical State University poultry 
farm of Greensboro, NC, and Sunrise Farms of Catskill, NY.  Upon receipt of embryos from the 
vendor, excrement and dirt should be removed from the surface of the egg with a dry towel, by 
vigorous, but gentle rubbing.  Development of the embryo is halted when the egg is placed in an 
environment under 65°F, therefore transport from the respective farm did not impact embryonic 
developing.  Placing the embryo in an incubator, whether desktop or cabinet, at temperatures 
above 85°F with more than 75% humidity is the ideal condition for development.  The 
experiments conducted in a Lyon Turn-X incubator and a GQF Digital Sportsman cabinet 
incubator.  Maintenance of ambient temperature and humidity are important factors for 
conducting the chicken chorioallantoic membrane assay. 
2.5.2 In ovo chorioallantoic membrane assay.  The in ovo chorioallantoic membrane 
involves allowing development of the embryo to occur inside the shell.  
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Figure 6.Method of performing the in ovo chick chorioallantoic membrane assay.  The embryo 
may be stored vertically (a) or horizontally (b).  (Vargas, 2007).  
After 3 days of incubation, 3-4 mL of albumen is extracted from the egg to increase the 
amount of air space, as shown in Figure 6b-(a).  Once the membrane has settled, the shell of the 
embryo is perforated to create a window.  This window allows for access to the chorioallantoic 
membrane and direct visualization of the tissue response to the implanted material.  The window 
can be created on the vertical or horizontal axis of the egg shell, as depicted in Figure 6a and b 
respectively.  Creating a window on the horizontal axis allowed for perforated embryos to be 
stored in the desktop Lyon incubator without modification to the incubator.  Sealing the window 
is also vital.  An improper seal to the eggshell allows for contamination, which is deleterious to 
b 
a 
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the experiment.  The fertilized eggs must be stored in an incubator that allows the eggs to be 
rotated on a consistent basis.  The eggs are rotated every hour to prevent nerve damage to the 
developing embryo.  It is ideal to assess the tissue response 24 hours after implantation and on a 
consistent schedule for the duration of the experiment.  The benefit of allowing the embryo to 
develop inside the shell is the nutrients that are provided to the developing embryo from the 
shell.  The duration of the experiment conducted was not extended to the point when the embryo 
required the calcium and minerals from the shell for bone development. 
2.5.3 Ex ovo chorioallantoic membrane assay. The ex ovo chorioallantoic membrane 
assay completely removes the developing embryo from the shell.   
  
Figure 7. Methods for performing the ex ovo chorioallantoic membrane assay. (a) Petri dish 
method. (b) Plastic sling method. 
Figure 7 shows the different methods of conducting the ex ovo chorioallantoic membrane assay.  
The contents of the egg can also be placed directly inside a petri dish and allowed to develop, 
Figure 7a.  The embryo is also allowed to develop in a plastic sling that is placed inside a cup of 
water, which creates a humidor for the embryo, Figure 7b.  The sling method is better for 
experiments that require more than one day.  The petri dish is an effective model, but an 
increased mortality rate was observed with this method, in comparison to the sling method.  The 
water allows the embryo to rotate at will, similar to what would occur in nature.  The water also 
provides a source of humidity, similar to the gas exchange that would occur from the hen sitting 
a b 
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on the eggs.  A sterilized petri dish encloses the cup.  Without the limitation of the square cut 
into the shell of the embryo, the ex ovo method allows for complete visualization of the entire 
embryonic development process.  As previously stated, the shell is useful in providing nutrients 
that are required for bone maturation and development, the duration of this experiment does not 
warrant the necessity of the shell. 
Table 5 
Comparison of in ovo and ex ovo chick chorioallantoic membrane assay 
 In ovo Ex Ovo 
Advantages The sources of calcium for 
building skeletal elements is kept 
Large chorioallantoic membrane area 
available for testing 
 Normal development of the 
embryo 
Direct visualization of the entire 
chorioallantoic membrane 
 High embryo survival rate Evaluation of several samples in one single 
embryo 
 Easy methodology No eggshell falling on chorioallantoic 
membrane 
 Sterility is not required Easy access to chorioallantoic membrane 
vasculature 
 Embryos can reach hatching In vivo observation of embryo development 
Limitations Small surface is exposed Difficult methodology (e.g. transfer the 
embryo to plastic dish, sterility requirements). 
 Difficult monitoring Low embryo survival rate 
 Risk of angiogenesis induced by 
eggshell pieces 
Do not reflect physiological conditions 
  Embryos cannot reach hatching 
(Vargas, 2007).  
When comparing the in ovo and ex ovo methods as demonstrated in Table 5, no advantage or 
limitation is more prevalent to consider the use of one method over the other.  The decision of 
use of one method should be determined by the length of time the specimens are required for 
experimentation, the extent to which the researchers would like the embryos to develop, and 
methods of post experimentation analysis.  Based on the research conducted in this study, 
utilizing both the in ovo and ex ovo methods, the plastic sling method provides better results in 
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comparison to simply opening the contents of the fertilize egg into a sterilized petri dish when 
using the ex ovo method; the in ovo method should be used when post experimentation analysis 
involves reconstruction and impact of the implant on the complete chorioallantoic membrane is 
to be assessed, versus assessment of a localized region.  If embryonic development requires the 
embryo to develop calcified tissue structures, it is more ideal to allow development to occur in 
ovo, with the shell in place to provide nutrients. 
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CHAPTER 3 
Materials and Methodology 
3.1 Implant Preparation 
 The effect of magnesium on angiogenesis was evaluated by several research methods.  
Pure magnesium, magnesium alloys, and salt solutions of expected corrosion products were 
used.   
3.1.1 AZ31 discs and rods. Magnesium AZ31 was purchased from Alfa Aesar.  The 
1.87 mm diameter wire was cut into 2 mm rods.  The rods were polished to a smooth finish and 
sterilized with 70% ethanol.  The rods were further cut into 0.5-1 mm rods and polished to 0.125 
micrometers, which was confirmed with digital calipers.  The polished discs were sterilized with 
ethanol prior to being placed on the surface of the chorioallantoic membrane.  These samples 
were also used for the immersion test. 
3.1.2 Lead wire.  Lead wire was used as a negative control.  .125mm diameter lead wire 
was cut into 2-3 mm length rods, sterilized with 70% ethanol, and directly placed on the surface 
of the membrane.   
3.1.3 Magnesium wire.  Pure magnesium wire (0.125mm) was purchased from 
Goodfellow.  Chromium acetate was used to clean the surface of the pure magnesium wire for 3 
minutes.  The wire was then cut into 2-3 mm samples.  The wire was either directly placed on the 
chorioallantoic membrane or affixed to a polystyrene ring.  
3.1.3.1 Polystyrene rings.  101 to 1000 µL Polystyrene pipette tips were cut into rings, 
polished to a smooth finish, and used to mark the location of implanted materials.   
3.1.3.1.1 Polydimethylsiloxane.  Polydimethylsiloxane (PDMS) is a silicone based 
polymer that is inert and biocompatible.  Sylgard 184 silicone elastomer base and Sylgard 184 
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silicone elastomer curing agent was used in a 10:1 ratio, respectively.  The materials were 
properly mixed for 2 minutes.  The PDMS is placed in the oven for 2-3 minutes to remove the 
bubbles from the mixture.  The mixture was used to affix the sample to the polystyrene ring.  
Once the desired specimen was affixed, it was then cured.  The PDMS was cure at 60°C for 1 
hour. 
3.1.3.1.2 Glass cover slips.  Five millimeter diameter glass cover slips were affixed to 
polystyrene rings using polydimethylsiloxane.  The glass cover slips were used as markers for 
implanted materials. 
3.1.3.1.3 Filter paper.  Whatman filter paper was hole punched to form a ring and serve 
as a marker for implantation sites for various materials during the course of the experiment.   
3.1.3.2 Vascular endothelial growth factor and polylactic-co-glycolic acid. Fifty six 
milligrams for polylactic-co-Glycolic Acid (PLGA) was dissolved in 1000 microliters of 
chloroform.  The solution was hand swirled until the PLGA was fully dissolved.  The wire was 
then allowed to air dry in the flow hood.  Twenty micrograms of vascular endothelial growth 
factor (VEGF) was purchased from Fisher Scientific and reconstituted in 1X phosphate buffer 
solution (PBS).  Twenty microliters of the VEGF and PBS solution was used to microdip the 
magnesium wire in an altered polystyrene pipette tip.  Each wire was dipped three times in the 
solution.  The VEGF wire was placed in a petri dish and stored at -20°C to prevent protein 
denaturation.  The samples were placed directly on the surface of the chorioallantoic membrane. 
3.1.4 Expected corrosion product solutions.  Salt solutions were prepared of aluminum 
chloride, calcium chloride, magnesium chloride, and zinc chloride at 1 millimole, 10 millimole, 
and 20 millimole concentrations in 1X phosphate buffered solution.  Phosphate buffered solution 
(1X) was used as an experimental control.  Twenty microliters of the solution was placed on a 
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glass cover slip that had a polystyrene ring attached to denote where the salt solution was placed 
on the glass cover slip.  The cover slip was then allowed to air dry, and then the sample was 
placed on the surface of the membrane.  Filter paper was also used as a marker in 
experimentations in which the 20 microliters of the denoted salt solution was directly placed on 
the surface of the membrane.  These solutions were chosen based on the composition of the 
magnesium alloys.  
3.1.5 Titanium rods and wire.  Titanium was used as a positive control.  Titanium wire 
(1.86 mm diameter) was cut into 2-3 mm length rods, polished to a smooth finish, and sterilized 
with 70% ethanol.  The titanium wire was directly placed on the surface of the membrane.  0.125 
mm diameter titanium wire was cut into 2-3 mm length rods, sterilized with 70& ethanol, and 
affixed to polystyrene rings for implantation on the chorioallantoic membrane.    
3.1.6 Mg-5Zn-0.3Ca.  Two millimeter and five millimeter diameter magnesium alloy 
composed of magnesium, 0.3% calcium, and 5% zinc was cut into 0.5-1 millimeter rods.  The 
rods were polished to 0.125 micrometers, which was confirmed with digital calipers.  The 
formed discs were sterilized with ethanol prior to being placed on the surface of the 
chorioallantoic membrane. These samples were also used in the immersion test. 
3.2 Chorioallantoic Membrane Assay 
 Fertilized chicken embryos were maintained at 37°C in an incubator for three days (72 
hours), upon receipt.  Prior to incubation, dirt, feathers, and excrement were carefully removed 
from the egg shells by dry wiping with hand paper towels.  The relative humidity of the 
incubator should be 86-100%.  The eggs should be stored so that the base lies horizontally.  The 
incubator rotates the eggs once every hour.   
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 3.2.1 In ovo chorioallantoic membrane assay. 
   
   
  
 
 
Figure 8.  Methodology of the In ovo chick Chorioallantic Membrane Assay 
 Residual moisture is removed from the surface of the egg, once it is removed from the 
incubator, Figure 8a.  On day 3 of development, a 1” x 1” piece of parafilm is placed left of the 
base to protect the area where the albumin will be drawn out.  Using a 10cc syringe, with an 18 
gauge needle, a small hole is drilled into the egg shell with the needle, Figure 8b.  The needle is 
driven into the egg at a 45° angle towards the bottom of the egg.  The needle is then used to draw 
3-4 mL of albumen.  Using a Dremel, a 3” x 3” square or circle is cut into the top surface of the 
a b c 
d e f 
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egg, Figure 8c and d.  Parafilm then used to cover the opening, Figure 8e and f.  The embryo is 
then returned to the desktop incubator to allow for further development of the chorioallantoic 
membrane, Figure 8g and h.  On embryonic day 5 photographic images are taken to track the 
developmental changes that occur.  After the embryos are photographed, a research specimen is 
placed on the chorioallantoic membrane with forceps, preferably in an area that is slightly 
vascularized, at a branching point.  Once the implant has been placed, photographic images are 
again taken to note any immediate changes that occur at the implantation site.  The embryo is 
then covered with parafilm and returned to the incubator.  Photographic images are taken during 
the course of development. 
The magnesium AZ31 rods were used in in ovo experimentation.  The implant was in place 3 
days and photographic images were taken every 24 hours.  The embryo was further visualized 
using Nanotom X-ray computed topography to analyze the corrosion product development. 
3.2.2 Ex ovo chorioallantoic membrane assay.   Any residual moisture on the surface 
of the egg is wiped with a dry papertowel, as shown in Figure 9a.   On embryonic day 3, the 
developing embryo’s shell is cracked an opened into a plastic sling resting atop a water filled 
petri dish.  A demonstrative representative of this is shown in Figure 9, images b, c, and d.   
 
   
b c a 
e 
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Figure 9. Methodology of the Ex ovo Chick Chorioallantoic Membrane Assay 
The eggshell is discarded in a hazardous waste bag, Figure 9e.  The sling is placed inside of a 
cup of 9 milliliters of water that has been warmed to 37°C, displayed in Figure 9f.  The sling is 
then covered with a sterilized petri dish lid, as shown in Figure 9g.  The apparatus is then 
returned to the climate controlled incubator to continue development, displayed in Figure 9, 
images h and i.  On embryonic day 5, the research specimen is placed on the chorioallantoic 
membrane after reference photographs have been taken of the membrane prior to implantation.  
Photographs were taken on a consistent basis for the duration of the experiment.   
3.3 Immersion test  
Magnesium AZ31 and Mg-5Zn-0.3Ca disk were placed in 10mL of Hank’s simulated 
body fluid in 15 milliliter centrifuge tubes.  The tubes were housed in a holder and placed on a 
horizontal rocker inside a 37°C incubator.  Initial pH and the pH of the solutions were taken daily 
for 7 days.  A sample was removed from solution daily to assess the impact of prolonged 
exposure to the solution to the magnesium alloys AZ31 and Mg-5Zn-0.3Ca.  After the pH was 
d f 
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taken, Hank’s simulated body fluid was removed and 10mL of 1M Hank’s simulated body fluid 
was placed in the centrifuge tube.  The tube was then returned to the rocker inside the incubator.  
The magnesium alloy samples removed daily for the duration of the experiment. 
3.4 Data Analysis 
 3.4.1 Microscopy 
3.4.1.1 Light.  A standard laboratory light microscope with a removable lens that allows 
for camera attachment was used for sequential photographic images. 
3.4.1.2 Scanning electron microscope and electron dispersive x-ray.  The Hitachi 
SU8000 Field Emission Scanning Electron Microscope (SEM) was used for analysis of surface 
morphology of the magnesium based alloys following implantation.  The samples were further 
characterized by EDX technology. 
3.4.2 Camera.  A Canon EOS-60D and Nikon D3100 were used to capture sequential 
photographic images for this study.  The Canon EOS-60D was used in conjunction with the light 
microscope. 
3.4.3 Nanotom.  The General Electric Phoenix Nanotom was used for non-destructive 
3D analysis and volume reconstruction of in ovo experimental specimens.  Phoenix CT 
Acquisition and Phoenix CT Reconstruction software was used for image acquisition and 
reconstruction. 
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CHAPTER 4 
Results 
4.1 Magnesium Wire.  
4.1.1 Pure magnesium wire ex ovo experimental results.  Pure magnesium wire began 
corrosion within twenty four hours of implantation, based upon change in appearance observed 
on photographic images displayed in Figure 10.  The weight of the wire was conducive to 
angiogenic development of the embryo, but was not fully incorporated.  With a dynamic model, 
it is imperative that the implant incorporate into the membrane.  As the embryo shifts, the 
implant shifts also, therefore incorporation of the implant is vital to the experimentation, 
especially when changes are tracked via daily photographic images.  Hallmark features of 
angiogenesis were observed in the ex ovo experiment, but the shifting of the embryo resulted in 
puncturing a blood vessel. 
  
  
Figure 10. Pure Mg wire ex ovo experimental results. 
Day 2 Day 3 
Day 0 
Mg Wire 
Mg Wire Day 1 
Mg Wire 
39 
 
Magnesium wire was suspended on polystyrene rings to provide a focal site for detection of 
angiogenic changes.  The results displayed in Figure 11 indicate that the weight of the pure 
magnesium wire did not comprise the angiogenic development of the embryo.  Corrosion of the 
magnesium was detectable within 24 hours of implantation.  Within two days of implantation, 
blood vessel development was detected along the length of the wire implant as the pure 
magnesium degraded on the chorioallantoic membrane. 
   
  
 
Figure 11. Pure Mg ex ovo results 
In a subsequent ex ovo experimentation of pure magnesium wire placed on the surface of the 
chorioallantoic membrane, the magnesium wire was able to fully degrade on the surface of the 
chorioallantoic membrane within 8 days of implantation, as shown in Figure 12.  The 
environment rich in proteins provided the ideal environment for corrosion to occur.  The 
chorioallantoic membrane surface is composed of several proteoglycans, glycoproteins, and 
other adhesive proteins.  Many intracellular proteins, similar to those found in the chorioallantoic 
membrane contain chloride channels.  The ubiquitous circulating proteins required for vessel 
development and the innate chloride ions also found on the membrane allow for corrosion of the 
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implanted material.  There were no notable changes in the number of blood vessels within the 
polystyrene ring, but the corroded magnesium was not deleterious to the development of the 
embryo. 
   
   
Figure 12. Pure Mg experimentation on ex ovo chorioallantoic membrane 
 4.1.2 Pure magnesium wire coated with vascular endothelial growth factor. 
Magnesium wire was coated with PLGA and VEGF, as described in the materials and 
methodology section , and used in an ex ovo experiment, the results are shown in Figure 13.  
After day 3 of implantation, photographic evidence displays the formation of a blood vessel 
along the length of the implant.  Degradation of the coated magnesium wire did not progress as 
quickly as observed in the uncoated magnesium wire, but more angiogenic development was 
observed.  PLGA has been shown to reduce the rate of magnesium corrosion in previous studies.  
Vascular endothelial growth factor is responsible for recruiting endothelial cells to the area for 
angiogenic development.  Serving as the positive control in this experiment, desired results were 
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achieved.  Despite the appearance of saturated blood, the capillary structure was not disturbed 
and the endothelium was intact for developed blood vessels. 
   
   
  
 
Figure 13. Pure magnesium wire coated with VEGF and PLGA ex ovo experimental results 
4.2 Magnesium AZ31 Rod 
4.2.1 In ovo experimental results. Magnesium alloy AZ31 was implanted onto the 
chorioallantoic membrane of an in ovo developing embryo.  The implant remained on the 
chorioallantoic membrane for 3 days. Figure 14a depicts the buildup of corrosion productions 
that is a direct result of the alloy being placed on the chorioallantoic membrane.   
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Figure 14. Magnesium AZ31 was implanted in ovo for 3 days.  
Increased amounts of corrosion products are displayed in Figure 14b.  Figure 14c and 14 clearly 
display blood vessel formation on the surface of the implanted material.  The Magnesium AZ31 
rod was integrated into the chorioallantoic membrane without eliciting a toxic response.  The 
chorioallantoic membrane was able to grow over the implant.  Corrosion products were further 
evaluated by Dr. Boyce Collins, utilizing the Nanotom X-ray computed topography technology.  
Blood vessel development occurred in the presence of the magnesium implant.  Further 
characterization would be required to determine the influence that magnesium AZ31 had on the 
angiogenic development.  
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 4.2.2 Nanotom ct x-ray reconstruction 
 
 
 
 
 
 
Figure 15. Nanotom X-Ray CT reconstruction of magnesium AZ31 in ovo experiment. 
Figure 15 demonstrates the post experimentation analysis capabilities of the in ovo chick 
chorioallantoic membrane assay with Nanotom X-ray CT technology.  The Nanotom is able to 
digitally remove the shell, revealing the contents of the fertilized egg, without disturbing the 
embryo.  The developing embryo was deceased prior to x-ray exposure.   The energy dispersed 
during image acquisition will euthanize the embryo.  The Nanotom can be used in future 
research experiments to analyze the broad spectrum of effects the implanted material has on the 
embryo, as opposed to the localized analysis that results from use of sequential photographic 
images. 
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4.3 Magnesium AZ31 Disc.  
 4.3.1 Ex ovo experimental results. 
 
  
  
 
   
Figure 16. Magnesium AZ31 ex ovo experimental results 
Figure 16 displays the photographic images for angiogenic changes that occurred for the 
experimentation of the interaction of Mg AZ31 disc with the ex ovo chick chorioallantoic 
membrane.  Magnesium based alloy implants were removed from the surface after 1 day Figure 
16a, 2 days Figure 16b, and three days Figure 16c.  The diameter of the test material used in this 
experiment, 5mm, was too large to explicitly capture the angiogenic changes.  Based on the data 
available, there were no notable angiogenic changes observed.  Magnesium AZ31 has a very 
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slow corrosion rate that is not ideal for use with the chick chorioallantoic membrane assay 
research model. 
 4.3.2 SEM analysis of magnesium AZ31 ex ovo. 
  
 
 
Figure 17. SEM analysis of magnesium AZ31 ex ovo 
Once the implanted samples displayed in Figure 17 were removed from the surface of the chick 
chorioallantoic membrane assay after 1 day (Figure 17a), 2 days (Figure 17b), and 3 days (Figure 
17c), they were analyzed on the HJitachi SU8000 Field Emission Scanning Electron Microscope.  
Analysis detected structural changes on the surface of the material that would indicate interaction 
between the chorioallantoic membrane and the magnesium alloy.  Further characterization was 
conducted by EDX technology. 
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4.4 Mg-5Zn-0.3Ca 
 4.4.1 Ex ovo 
 
  
  
 
   
Figure 18. Mg-5Zn-0.3Ca ex ovo experimental results  
The magnesium alloy containing zinc and calcium fabricated in the laboratory of Dr. Zhigang Xu 
was used to provide valuable information on the degradation properties of magnesium alloys.  
The quickly corrosive alloy is ideal for use in the chorioallantoic membrane assay.  The alloy 
was cut into .25 micron x 2 mm and 5mm disc and utilized in an ex ovo experiment, as shown in 
Figure 18.  A disc was removed each day for 3 days for analysis under scanning electron 
micrscopy and electron dispersive x-ray technologies.  The highly corrosive magnesium alloy 
was not detrimental to the angiogenic development of the embryo.  The interaction between the 
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proteins of the chorioallantoic membrane and the alloy caused an increase in the presence and 
formation of hydrogen gas, therefore making photographic detection of angiogenesis difficult to 
acquire.   
4.4.2 SEM analysis of Mg-5Zn-0.3Ca ex ovo 
  
 
 
Figure 19.SEM analysis of Mg-5Zn-0.3Ca ex ovo 
Following sequential photographs of the interaction between the magnesium alloy Mg-5Zn-
0.3Ca, the implanted samples used in Figure 19 were further characterized via SEM to detect 
surface alterations that resulted from the material being exposed to the chorioallantoic 
membrane. The Mg-5Zn-0.3Ca implants were removed from the surface of the chorioallantoic 
membrane after 1 day, Figure 19a; 2 days, Figure 19b; and 3 days, Figure 19c.  Unlike the 
formation of corrosion products as displayed in the SEM analysis of magnesium AZ31, the ex 
ovo experimentation of Mg-5Zn-0.3Ca resulted in material loss, or corrosion of the material, 
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with increased exposure to the surface of the chick chorioallantoic membrane.  The material was 
further characterized by EDX technology. 
4.5 EDX Analysis of Magnesium Based Alloys.  
Table 6 
Comparative data of the EDX detection analysis  
Element C O Mg P Cl Ca Zn Al 
MgAZ31 Day 1 43.88 32.26 5.18 3.05 0.31 0.00 0.00 0.55 
MgAZ31 Day 2 47.19 8.08 20.25 9.16 0.52 0.87 0.00 9.91 
MgAZ31 Day 3 76.14 6.91 5.98 7.07 1.34 0.01 0.01 0.04 
Mg-5Zn-0.3Ca Day 1 0.00 59.43 6.90 14.17 1.84 17.65 0.00 0.00 
Mg-5Zn-0.3Ca Day 2 0.00 57.24 2.79 16.73 1.68 21.54 0.00 0.00 
Mg-5Zn-0.3Ca Day 3 0.00 38.92 4.32 24.76 1.59 27.92 2.48 0.00 
The test materials used for the ex ovo experimentation of magnesium based alloys AZ31 and 
Mg-5Zn-0.3Ca were characterized using EDX technology to determine the significant elements 
present on surface of the material that was directly in contact with the chorioallantoic membrane 
and the Hank’s SBF solution for the MgAZ31 and Mg-5Zn-0.3Ca, respectively, and displayed in 
Table 6.  The data provided displays the trend of increased carbon detection on the surface of 
AZ31, with increased exposure to the membrane surface.  Elemental carbon detection on the 
surface of the implant is indicative of incorporation of the material to the membrane.  Protein 
adsorption is one of the key features of angiogenesis.  Despite the fact that MgAZ31 does not 
produce significant corrosion products, the results garnered reveal that the test material is 
biocompatible with the environment.  Subsequent histological testing could reveal the impact of 
the alloy on the membrane.  Analysis of the prevalent atoms present on the surface of the Mg-
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5Zn-0.3Ca implants displayed in Table 6 exhibit a trend of increase calcium phosphate 
production on the surface of the material with prolonged expsosure to Hank’s SBF solution.  The 
high chloride content environment produced by the components of the solution provides an ideal 
environment for magnesium corrosion.  Mg-5Zn-0.3Ca is an alloy that is fabricated for the 
analysis of corrosion products.  The increased oxygen production observed in the Mg-5Zn-0.3Ca 
results, in comparison to AZ31, is of no surprise and caused by the increased corrosion rate of 
Mg-5Zn-0.3Ca in comparison to AZ31. 
4.6 Lead wire ex ovo experimental results 
   
   
Figure 20. Lead wire ex ovo experimentation results 
Lead wire (.125 microns x 2 mm) served as the negative control for the experiment, Figure 20.  
The small amount of lead present was not a toxic dose to the developing embryo, but by day 5 of 
implantation, there are visible changes in the location of the blood vessels.  The presence of the 
lead wire caused blood vessels to become redirected away from the site of implantation.  Desired 
results were achieved by the presence of the lead wire.  
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CHAPTER 5 
Discussion and Future Research 
Analysis of the results showed that the chicken chorioallantoic membrane assay is a 
viable method for understanding the relationship between magnesium degradation and 
angiogenesis.  The results provided by the ex ovo or the in ovo method were shown to be useful.  
The in ovo method allows for further detection via Nanotom x-ray computed topography 
technology, but a method of differentiating blood vessels from other tissue types should be in 
place prior to beginning the experiment.  The best results for the ex ovo method were garnered 
when using the hammock method of suspending the embryo contents in a plastic sling above 
water and placed in the incubator, rather than allowing the embryo to develop simply in a petri 
dish.  The hammock method allows the embryo to move, as it would if it were in a shell, while 
developing.  The petri dish method did not allow the embryo to rotate, but this was less of a 
hindrance when it is desired to have the implant remain at the same site for the course of the 
experiment.  For short term experiments, those lasting a few hours, to no more and 1 day, the 
petri dish method may provide significant results, with embryonic developing being of no 
concern.  The table top incubator used did not provide any different results from the cabinet 
incubator.  The cabinet incubator was able to hold more specimens in comparison to the 15 
embryos that could be held in the table top incubator. The humidity control was of ease with both 
incubators. 
Implanting pure magnesium wire on the chorioallantoic membrane yield results that 
suggest magnesium wire is compatible with the chorioallantoic membrane, the embryo is able to 
incorporate the magnesium into the membrane, and the environment provided by the 
chorioallantoic membrane is suitable for degradation of the material.  Coating the pure 
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magnesium wire with vascular endothelial growth factor encouraged blood vessel growth along 
the length of the wire and the PLGA slowed the rate of degradation of the wire.  These results 
suggest that PLGA is capable of controlling the rate of degradation and VEGF encourages 
angiogenic development, both were desired results.  In larger models, the key concepts may be 
pivotal in developing an implant that has sustained release of a drug or growth factor that is 
beneficial for healing, but allows the implant to remain in place for a desired period of time.   
Magnesium alloy AZ31 was shown to provide more valuable results when thin disk were 
used, as opposed to rods or thicker disc, in the ex ovo experiments. Detection of the disc and 
wire was difficult when imploring Nanotom CT X-rays for post implantation data analysis.  It is 
imperative that the sample size be proportional to the membrane, to not disturb the membrane, 
become dislodged during transport into and out of the incubator, or sink to the bottom of the 
embryonic tissue and yield no interaction with the chorioallantoic membrane, but the yolk.  This 
was observed when the rods were used versus very small disk.  The use of magnesium AZ31 in 
various shapes suggest that it is beneficial to utilize research samples that corrode within 5 days 
to assess the impact the material and the degradation by products have on angiogenesis.  The use 
of commercially available AZ31, initially, limited the amount of data that could be collected 
during the duration of the experiment. More experimentation with the magnesium alloy AZ31 
would not have proven to be beneficial due to the lack of buildup of degradative byproducts, as 
also seen in the immersion test.  There was minimal interaction and impact with the use of AZ31.  
Calcium phosphate and hydrogen gas production were observed.  Magnesium AZ31 is 
biocompatible with the chorioallantoic membrane, as evident with the proteins that were able to 
attach directly on the surface of the implant.  The slow degradation rate of AZ31 makes it a less 
than desirable material to use in this research environment.  The Engineering Research Center 
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for Revolutionizing Metallic Biomaterials fabricated magnesium zinc calcium alloy provided the 
most desirable corrosion results of all the research samples used.  The alloy was used as a disk in 
ex ovo experiments and in the immersion test.  The results of the in vivo and in vitro yield similar 
results, suggesting that the material is biocompatible with the chorioallantoic membrane, the 
material is capable of being incorporated into the membrane, and the degradation products of the 
alloy are not detrimental to the membrane.  In the ex ovo experiment, the alloy began interacting 
with the membrane immediately. Hydrogen gas formed as soon as the implant was placed on the 
membrane.  Hydrogen gas production continued and was visible for the duration of the 
experiment.  Within 3 days of implantation, visible signs of material loss were captured by the 
photographic images, and this had no deleterious effects on embryonic development.  The only 
drawback to the use of the Mg-5Zn-0.3Ca alloy was the diameter of the implant.  The five 
millimeter diameter disk was too large and caused the production of a large amount of hydrogen, 
inhibiting photographic capture of the blood vessels immediately surrounding the implantation 
site.  A ring of .125mm thickness, with a 5 mm diameter would be a reasonable alternative.  It 
would provide fast degradation, but allows for detection of blood vessel changes at the same 
time. 
The results of implantation of the positive and negative controls, titanium and lead, 
respectively, confirmed that implants should be in proportion to the membrane.  A small amount 
of lead present on the membrane was not deleterious to embryonic development, whereas a large 
titanium rod was too large in proportion to the membrane to allow development.  The aluminum 
chloride, calcium chloride, magnesium chloride, and zinc chloride solutions did not provide any 
viable results.  This may be attributed to the experimentation methods used or weakened 
membranes of the embryos prior to implantation.  The magnesium chloride solution at 1 
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millimole concentration was the only salt solution that was able to survive 24 hours of 
implantation.  The blood vessels directly surrounding the filter paper used remained intact while 
those distal to the implantation site were no longer viable.  Based on the experimentations that 
were conducted, these results suggest that the embryo had a weak membrane prior to 
implantation. 
Previous knowledge of embryo development would have improved the likelihood of 
achieving desired results, as more time could have been spent on adequate sample preparation.  It 
would be more desirable to have a consistent source for providing embryos of similar quality.  
The donated eggs were greatly appreciated, but understanding acquiring embryos from a 
company that profits from developed chicks versus eggs implies that the best available eggs will 
be allowed to fully developed and those that do not fare as well will be donated for research.  
Many cull eggs were used for experimentation in comparison to high quality eggs that may have 
been available from egg distributors.  The cull egg membranes were typically weaker.  Future 
research on the difference between egg sources may prove beneficial in progressing with this 
research model.  Developing a protocol requires many trials and errors.  Of the thousands of eggs 
that were assessed during the course of thesis research, the number that provided viable research 
results was in the teens.  For future research, I would suggest that the eggs are acquired from the 
same vendor each time to ensure that factor of the experiment is controlled every time.  I would 
suggest the use of implants that are proportional to the size of the embryo. 
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